Skip to content

Clinical trials

Carcinoma, Renal Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: United Kingdom Clear all

161 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20034
20043
20053
20064
200710
200811
20093
20105
20113
20128
20136
20148
20157
20168
201712
20186
20199
202010
202111
20228
20235
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Terminated20
Active, not recruiting16
Recruiting13
Unknown status11
Withdrawn2
No longer available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals16
Merck Sharp & Dohme LLC13
Bayer10
Pfizer10
Hoffmann-La Roche9
Bristol-Myers Squibb5
Exelixis5
AstraZeneca4
Cancer Research UK4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell161
Kidney Neoplasms31
Carcinoma, Non-Small-Cell Lung25
Neoplasms24
Melanoma19
Neoplasm Metastasis15
Colorectal Neoplasms14
Triple Negative Breast Neoplasms11
Ovarian Neoplasms10
Stomach Neoplasms10

Trials

Showing 1 to 25 of 161. Each trial links to its page on Pharma Observatory.

61 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.